Abbott J Dawn, Kip Kevin E, Vlachos Helen A, Sawhney Neil, Srinivas Vankeepuran S, Jacobs Alice K, Holmes David R, Williams David O
Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island, USA.
Am J Cardiol. 2006 Jun 15;97(12):1691-6. doi: 10.1016/j.amjcard.2005.12.067. Epub 2006 Apr 21.
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) has a lower success rate than PCI for non-CTO lesions. We sought to determine trends in the treatment of CTOs within the current interventional era. Using 4 sequential recruitment waves of the National Heart, Lung, and Blood Institute Dynamic Registry, we assessed the relative prevalence and success rates in treating CTO (n=371) versus non-CTO (n=4,802) lesions over a 7-year period (1997 to 2004). Characteristics of attempted lesions and factors associated with PCI outcome were evaluated. CTO lesion attempts decreased by 41% over time, from 9.6% (1997 to 1998) to 5.7% (2004, p<0.0001 for trend). More contemporary CTO lesions were longer (22.4 vs 17.0 mm, p=0.006 for trend), had thrombus less often (21.3% vs 35.4%, p=0.03 for trend), and were more often treated with stents (69.8% vs 45.4% p=0.02). The rate of successful intervention for CTO lesions decreased nonsignificantly during this time, from 79.7% to 71.4% (p=0.18). Using multivariable analysis, female gender (adjusted odds ratio 0.42, 95% confidence interval 0.20 to 0.88, p=0.02), and thrombus (adjusted odds ratio 0.31, 95% confidence interval 0.15 to 0.61, p=0.0008) were associated with higher success rates, whereas the presence of severe noncardiac disease (adjusted odds ratio 1.91, 95% confidence interval 1.05 to 3.45, p=0.03) was associated with a higher risk for PCI failure. Recruitment wave and patient age were not independently related to lesion success. In conclusion, during the PCI period of 1997 to 2004, CTO lesions were attempted less frequently and success rates did not increase, indicating a need for new operator techniques or device technologies to treat this important lesion subset by a percutaneous approach.
慢性完全闭塞病变(CTO)的经皮冠状动脉介入治疗(PCI)成功率低于非CTO病变的PCI治疗。我们试图确定当前介入治疗时代CTO治疗的趋势。利用美国国立心肺血液研究所动态注册研究的4个连续招募阶段,我们评估了7年期间(1997年至2004年)治疗CTO病变(n = 371)与非CTO病变(n = 4802)的相对患病率和成功率。评估了尝试治疗病变的特征以及与PCI结果相关的因素。随着时间的推移,CTO病变尝试次数下降了41%,从1997年至1998年的9.6%降至2004年的5.7%(趋势p<0.0001)。更现代的CTO病变更长(22.4 vs 17.0 mm,趋势p = 0.006),血栓形成较少(21.3% vs 35.4%,趋势p = 0.03),且更多地接受支架治疗(69.8% vs 45.4%,p = 0.02)。在此期间,CTO病变的成功干预率无显著下降,从79.7%降至71.4%(p = 0.18)。采用多变量分析,女性(调整后的优势比0.42,95%置信区间0.20至0.88,p = 0.02)和血栓(调整后的优势比0.31,95%置信区间0.15至0.61,p = 0.0008)与较高的成功率相关,而严重非心脏疾病的存在(调整后的优势比1.91,95%置信区间1.05至3.45,p = 0.03)与PCI失败风险较高相关。招募阶段和患者年龄与病变成功无独立相关性。总之,在1997年至2004年的PCI期间,CTO病变的尝试频率降低,成功率未增加,这表明需要新的术者技术或设备技术来通过经皮途径治疗这一重要的病变亚组。